--- title: "Vicapsys Life Sciences (VICP) stock and investor profile" url: "https://aibio.space/companies/vicapsys-life-sciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Vicapsys Life Sciences, Inc. (OTC: VICP), United States. The directory classifies it as Pharmaceuticals: Major." --- VICP Vicapsys Life Sciences, Inc. OTC · United States # Vicapsys Life Sciences (VICP) news Vicapsys Life Sciences, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker VICP, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Vicapsys Life Sciences news We have not published a story on Vicapsys Life Sciences yet. When there is news, it will appear here. ## Vicapsys Life Sciences at a glance - **Ticker**: VICP - **Listing**: OTC - **Country**: United States - **Cash, Sep 30, 2024**: $89,569 ### Related companies - [Retension Pharmaceuticals](https://aibio.space/companies/retension-pharmaceuticals/) NASDAQ: RTSN - [Retrieve Medical Holdings](https://aibio.space/companies/retrieve-medical/) OTC: RMHI - [Acurx Pharmaceuticals](https://aibio.space/companies/acurx-pharmaceuticals/) NASDAQ: ACXP - [Dare Bioscience](https://aibio.space/companies/dare-bioscience/) NASDAQ: DARE - [Viskase Holdings](https://aibio.space/companies/viskase/) OTC: VISK - [EOM Pharmaceutical Holdings](https://aibio.space/companies/eom-pharmaceutical/) OTC: IMUC - [Xenetic Biosciences](https://aibio.space/companies/xenetic-biosciences/) NASDAQ: XBIO - [PDS Biotechnology](https://aibio.space/companies/pds-biotechnology/) NASDAQ: PDSB ### Also on OTC - [Nano Mobile Healthcare](https://aibio.space/companies/nano-mobile-healthcare/) VNTH - [INTERPACE BIOSCIENCES, INC.](https://aibio.space/companies/interpace-biosciences/) IDXG - [Standard Dental Labs](https://aibio.space/companies/standard-dental-labs/) TUTH - [Abpro Holdings](https://aibio.space/companies/abpro/) ABPO - [Avenir Wellness Solutions](https://aibio.space/companies/avenir-wellness-solutions/) AVRW - [Regen Biopharma](https://aibio.space/companies/regen-biopharma/) RGBP ## Vicapsys Life Sciences annual financials | Line | FY2023 | FY2022 | |---|---|---| | Research and development | [$15,267](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | [$13,097](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | | Net income (loss) | [-$1.2 million](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | [-$984,790](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | | Cash from operations | [-$417,524](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | [-$238,197](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | | Cash and equivalents | [$9,422](https://www.sec.gov/Archives/edgar/data/1468639/000149315225001743/) | [$14,097](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/) | Latest balance sheet, Sep 30, 2024 (10-Q): cash and equivalents $89,569. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Vicapsys Life Sciences What is the ticker symbol of Vicapsys Life Sciences? Vicapsys Life Sciences, Inc. trades under the ticker VICP on OTC. Where is Vicapsys Life Sciences listed? Vicapsys Life Sciences, Inc. is listed on OTC. What is the SEC CIK of Vicapsys Life Sciences? The SEC Central Index Key (CIK) for Vicapsys Life Sciences, Inc. is 1468639. Its filings are on SEC EDGAR. How many shares does Vicapsys Life Sciences have outstanding? 32,371,299 shares as of 2024-12-13, per the cover page of its 10-Q filed 2025-01-10. Which country or territory is Vicapsys Life Sciences listed under? Our directory records Vicapsys Life Sciences, Inc. under United States. What does Vicapsys Life Sciences do? Our directory classifies Vicapsys Life Sciences, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Vicapsys Life Sciences? The ISIN recorded for Vicapsys Life Sciences, Inc. is US92560A1060. Does aibio.space cover Vicapsys Life Sciences? aibio.space lists Vicapsys Life Sciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Vicapsys Life Sciences incorporated? SEC records list its state or country of incorporation as FL. Is Vicapsys Life Sciences profitable? Vicapsys Life Sciences, Inc. reported a net loss of $1.2 million for the fiscal year ended Dec 31, 2023, and used $417,524 of cash in operations, per its annual report to the SEC. How much does Vicapsys Life Sciences spend on research and development? $15,267 in the fiscal year ended Dec 31, 2023, per its annual report. How much cash does Vicapsys Life Sciences have? $89,569 in cash at Sep 30, 2024, per its 10-Q. What is Vicapsys Life Sciences's market cap? We do not publish live share prices. In its annual report, Vicapsys Life Sciences, Inc. put the market value of shares held by non-affiliates (public float) at $4.7 million as of Jun 30, 2024. Is Vicapsys Life Sciences a smaller reporting company? SEC records list Vicapsys Life Sciences, Inc.'s filer category as: Non-accelerated filer
Smaller reporting company
Emerging growth company. Where is Vicapsys Life Sciences headquartered? SEC records list its business address as 1735 BUFORD HIGHWAY, CUMMING, GA, 30041. ## Investor discussion: Vicapsys Life Sciences Members talk about Vicapsys Life Sciences (VICP). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Vicapsys Life Sciences, newest first. Each line links the filing it comes from. 1. 2025-03-27 Listings Filed to end its SEC reporting. SEC Form 15-12G. [Source](https://www.sec.gov/Archives/edgar/data/1468639/000164117225000877/form15-12g.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:VICP on TradingView](https://www.tradingview.com/symbols/OTC-VICP/). ## SEC filings and registration - **SEC name**: Vicapsys Life Sciences, Inc. - **CIK**: 1468639 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: VICP (OTC) - **State or country of incorporation**: FL - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company
Emerging growth company - **Business address**: 1735 BUFORD HIGHWAY, CUMMING, GA, 30041 - **Phone**: 470-514-4013 - **Shares outstanding**: 32,371,299 as of 2024-12-13 (10-Q filed 2025-01-10) - **Former names**: SSGI, INC. ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/1468639/000149315225001779/form10-q.htm) filed 2025-01-10 - [10-Q](https://www.sec.gov/Archives/edgar/data/1468639/000149315225001776/form10-q.htm) filed 2025-01-10 - [10-Q](https://www.sec.gov/Archives/edgar/data/1468639/000149315225001743/form10-q.htm) filed 2025-01-10 - [10-K](https://www.sec.gov/Archives/edgar/data/1468639/000149315224041809/form10-k.htm) filed 2024-10-21 - [8-K](https://www.sec.gov/Archives/edgar/data/1468639/000149315223046217/form8-k.htm) filed 2023-12-27 - [10-Q](https://www.sec.gov/Archives/edgar/data/1468639/000149315223040951/form10-q.htm) filed 2023-11-14 - [10-Q](https://www.sec.gov/Archives/edgar/data/1468639/000149315223028151/form10-q.htm) filed 2023-08-14 - [S-1](https://www.sec.gov/Archives/edgar/data/1468639/000149315223023181/forms-1.htm) filed 2023-06-30 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001468639), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Vicapsys Life Sciences, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker VICP, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Vicapsys Life Sciences, Inc. - **Ticker**: VICP - **Listing**: OTC - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US92560A1060 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-VICP/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/vicapsys-life-sciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Vicapsys Life Sciences (VICP) stock and investor profile", 2026-10-31, https://aibio.space/companies/vicapsys-life-sciences/